NCT00607802撤回不适用
White Cell Transfer as Cancer Therapy
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 主要终点
- Safety
研究概览
简要总结
RATIONALE: White blood cells from donors may be able to kill cancer cells in patients with cancer.
PURPOSE: This clinical trial is studying the side effects of donor white blood cell infusion in treating patients with metastatic or unresectable cancer.
详细描述
OBJECTIVES:
Primary
- Determine the safety of white blood cell infusion in patients with metastatic or unresectable cancer.
Secondary
- Determine the efficacy of this therapy in these patients.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- — 至 120 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Safety
次要结局
- Response (complete response, partial response, stable disease, or disease progression)
研究者
相似试验
已完成
2 期
Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationChronic Myeloproliferative DisordersGestational Trophoblastic TumorKidney CancerMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesTesticular Germ Cell TumorBreast CancerOvarian CancerLeukemiaSarcomaLymphomaNeuroblastomaNCT00003887Fred Hutchinson Cancer Center
已完成
2 期
Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow TransplantationMultiple Myeloma and Plasma Cell NeoplasmNCT00003153Eastern Cooperative Oncology Group22
已完成
1 期
Activated White Blood Cells With ASCT for Newly Diagnosed Multiple MyelomaMultiple Myeloma and Plasma Cell NeoplasmNCT00566098Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins26
终止
1 期
Therapeutic Autologous Lymphocytes, Aldesleukin, and Denileukin Diftitox in Treating Patients With Stage III-IV MelanomaRecurrent MelanomaStage III MelanomaStage IV MelanomaNCT00945269Fred Hutchinson Cancer Center3
已完成
不适用
Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell TransplantMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesLymphomaLeukemiaNCT00534118Roswell Park Cancer Institute39